Cresco Labs (CRLBF) Cash & Current Investments (2019 - 2026)
Cresco Labs (CRLBF) posted Cash & Current Investments of $63.6 million for Q1 2026, down 30.21% on a QoQ basis from $91.1 million in Q4 2025, and up 1709.65% year-over-year from $3.5 million in Q1 2025.
Cresco Labs (CRLBF) Cash & Current Investments (2019 - 2026) Analysis & Trends
Cresco Labs' Cash & Current Investments history runs 8 years deep, the most recent figure standing at $63.6 million for Q1 2026.
- Quarterly Cash & Current Investments rose 1709.65% year-over-year to $63.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63.6 million (up 431.64% YoY) and the FY2025 annual result came in at $91.1 million, up 2548.62% from the prior year.
- Cash & Current Investments was $63.6 million for Q1 2026 at Cresco Labs, down from $91.1 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $228.7 million in Q1 2022 and bottomed at $1.7 million in Q1 2024.
- A 5-year average of $59.7 million and a median of $33.3 million in 2025 frame the typical range for Cash & Current Investments.
- Peak annual rise in Cash & Current Investments reached 2548.62% in 2025, while the deepest fall reached 97.28% in 2025.
- Cresco Labs' Cash & Current Investments stood at $228.7 million in 2022, then tumbled by 52.55% to $108.5 million in 2023, then sank by 96.83% to $3.4 million in 2024, then surged by 2548.62% to $91.1 million in 2025, then tumbled by 30.21% to $63.6 million in 2026.
- Business Quant data shows CRLBF's Cash & Current Investments at $63.6 million in Q1 2026, $91.1 million in Q4 2025, and $33.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 3.74 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 1.94 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 4.06 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 2.15 Bn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 1.80 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.32 Bn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 428.00 Mn |
| 10 | Cresco Labs | 245.85 Mn | 182.28 Mn | 75.45 Mn | 63.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.57 Mn |
| Dec 31, 2025 | 91.09 Mn |
| Sep 30, 2025 | 33.29 Mn |
| Jun 30, 2025 | 3.15 Mn |
| Mar 31, 2025 | 3.51 Mn |
| Dec 31, 2024 | 3.44 Mn |
| Sep 30, 2024 | 3.26 Mn |
| Jun 30, 2024 | 115.95 Mn |
| Mar 31, 2024 | 1.75 Mn |
| Dec 31, 2023 | 108.52 Mn |
| Mar 31, 2022 | 228.70 Mn |
| Dec 31, 2021 | 5.12 Mn |
| Sep 30, 2021 | 202.41 Mn |
| Jun 30, 2021 | 135.23 Mn |
| Mar 31, 2021 | 262.44 Mn |
| Dec 31, 2020 | 8.87 Mn |
| Sep 30, 2020 | 59.62 Mn |
| Mar 31, 2020 | 70.03 Mn |
| Dec 31, 2019 | 1.15 Bn |